Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $39.14M | $54.29M | -27.90% |
Cost of Revenue | $56.68M | $32.44M | +74.69% |
Operating Income | $-539.8M | $-295.24M | -82.84% |
Net Income | $-536.64M | $-284.75M | -88.46% |
EPS (Basic) | $-1.27 | $-1.12 | -13.39% |
EPS (Diluted) | $-1.27 | $-1.12 | -13.39% |
R&D Expense | $379.33M | $216.09M | +75.55% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $1.4B | $726.5M | +92.64% |
Current Assets | $714.11M | $474.17M | +50.60% |
Total Liabilities | $352.58M | $201.94M | +74.60% |
Current Liabilities | $155.1M | $108.89M | +42.44% |
Stockholders' Equity | $1.05B | $524.56M | +99.59% |
Cash & Equivalents | $659.84M | $427.65M | +54.29% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-325.74M | $-243.74M | -33.64% |
Investing Cash Flow | $-15.63M | $-15.4M | -1.49% |
Financing Cash Flow | $389.53M | $293.48M | +32.73% |
D&A | $64.22M | $23.54M | +172.79% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -1379.0% | -543.8% | -835.26% |
Net Margin | -1371.0% | — | — |
ROE | -51.3% | — | — |
ROA | -38.3% | — | — |
Current Ratio | $4.604 | — | — |
Debt to Equity | $0.337 | — | — |
Other companies in Biotechnology